KBC Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $238M | Sell |
8,471,914
-721,799
| -8% | -$19.2M | 0.6% | 22 |
|
|
2025
Q4 | $229M | Buy |
9,193,713
+706,426
| +8% | +$17.8M | 0.52% | 32 |
|
|
2025
Q3 | $216M | Buy |
8,487,287
+5,066,200
| +148% | +$125M | 0.52% | 30 |
|
|
2025
Q2 | $82.9M | Sell |
3,421,087
-80,018
| -2% | -$1.87M | 0.22% | 91 |
|
|
2025
Q1 | $88.7M | Buy |
3,501,105
+199,736
| +6% | +$5.23M | 0.28% | 80 |
|
|
2024
Q4 | $87.6M | Buy |
3,301,369
+195,936
| +6% | +$5.31M | 0.24% | 90 |
|
|
2024
Q3 | $89.9M | Buy |
3,105,433
+639,985
| +26% | +$18.7M | 0.27% | 76 |
|
|
2024
Q2 | $69M | Sell |
2,465,448
-7,577,179
| -75% | -$209M | 0.21% | 92 |
|
|
2024
Q1 | $279M | Buy |
10,042,627
+5,666,590
| +129% | +$157M | 0.89% | 19 |
|
|
2023
Q4 | $126M | Buy |
4,376,037
+1,246,769
| +40% | +$37.7M | 0.45% | 43 |
|
|
2023
Q3 | $104M | Buy |
3,129,268
+144,522
| +5% | +$5.11M | 0.42% | 49 |
|
|
2023
Q2 | $109M | Sell |
2,984,746
-730,024
| -20% | -$28.4M | 0.45% | 51 |
|
|
2023
Q1 | $152M | Sell |
3,714,770
-191,774
| -5% | -$8.28M | 0.64% | 27 |
|
|
2022
Q4 | $200M | Sell |
3,906,544
-214,422
| -5% | -$10.3M | 0.97% | 18 |
|
|
2022
Q3 | $180M | Buy |
4,120,966
+57,804
| +1% | +$2.81M | 0.94% | 17 |
|
|
2022
Q2 | $213M | Buy |
4,063,162
+671,884
| +20% | +$34.2M | 1.06% | 12 |
|
|
2022
Q1 | $176M | Buy |
3,391,278
+591,086
| +21% | +$30.7M | 0.69% | 27 |
|
|
2021
Q4 | $165M | Buy |
2,800,192
+764,806
| +38% | +$37.9M | 0.55% | 40 |
|
|
2021
Q3 | $87.5M | Sell |
2,035,386
-1,165,784
| -36% | -$51.6M | 0.32% | 71 |
|
|
2021
Q2 | $125M | Buy |
3,201,170
+521,472
| +19% | +$20.3M | 0.23% | 106 |
|
|
2021
Q1 | $97.1M | Buy |
2,679,698
+435,176
| +19% | +$15.5M | 0.2% | 128 |
|
|
2020
Q4 | $443M | Sell |
2,244,522
-420,157
| -16% | -$15.4M | 0.19% | 141 |
|
|
2020
Q3 | $92.8M | Sell |
2,664,679
-3,565,424
| -57% | -$125M | 0.27% | 83 |
|
|
2020
Q2 | $193M | Buy |
6,230,103
+3,034,904
| +95% | +$103M | 0.64% | 31 |
|
|
2020
Q1 | $98.9M | Buy |
3,195,199
+537,538
| +20% | +$18.3M | 0.83% | 20 |
|
|
2019
Q4 | $98.8M | Sell |
2,657,661
-1,516,216
| -36% | -$54M | 0.62% | 27 |
|
|
2019
Q3 | $142M | Buy |
4,173,877
+302,005
| +8% | +$11M | 1.04% | 9 |
|
|
2019
Q2 | $159M | Sell |
3,871,872
-322,002
| -8% | -$12.8M | 1.23% | 7 |
|
|
2019
Q1 | $169M | Buy |
4,193,874
+81,732
| +2% | +$3.27M | 1.39% | 4 |
|
|
2018
Q4 | $170M | Sell |
4,112,142
-15,508
| -0.4% | -$644K | 1.9% | 3 |
|
|
2018
Q3 | $173M | Buy |
4,127,650
+494,942
| +14% | +$19.1M | 1.3% | 8 |
|
|
2018
Q2 | $125M | Sell |
3,632,708
-218,743
| -6% | -$7.48M | 1.09% | 8 |
|
|
2018
Q1 | $130M | Buy |
3,851,451
+578,086
| +18% | +$19.9M | 1.2% | 7 |
|
|
2017
Q4 | $112M | Sell |
3,273,365
-213,144
| -6% | -$7.27M | 0.96% | 12 |
|
|
2017
Q3 | $118M | Buy |
3,486,509
+59,510
| +2% | +$1.91M | 1.07% | 13 |
|
|
2017
Q2 | $109M | Sell |
3,426,999
-163,743
| -5% | -$5.16M | 1.05% | 13 |
|
|
2017
Q1 | $117M | Sell |
3,590,742
-1,637,134
| -31% | -$51.6M | 1.05% | 11 |
|
|
2016
Q4 | $161M | Buy |
5,227,876
+543,448
| +12% | +$16.6M | 1.6% | 4 |
|
|
2016
Q3 | $151M | Buy |
4,684,428
+1,817,240
| +63% | +$60.8M | 1.78% | 4 |
|
|
2016
Q2 | $95.8M | Buy |
2,867,188
+172,912
| +6% | +$5.52M | 1.37% | 6 |
|
|
2016
Q1 | $75.8M | Buy |
2,694,276
+472,060
| +21% | +$13.5M | 1.26% | 6 |
|
|
2015
Q4 | $68.1M | Buy |
2,222,216
+245,629
| +12% | +$7.73M | 1.25% | 5 |
|
|
2015
Q3 | $58.9M | Sell |
1,976,587
-1,027,471
| -34% | -$32.9M | 1.18% | 7 |
|
|
2015
Q2 | $95.6M | Sell |
3,004,058
-102,727
| -3% | -$3.35M | 1.23% | 4 |
|
|
2015
Q1 | $103M | Sell |
3,106,785
-402,502
| -11% | -$12.8M | 1.31% | 5 |
|
|
2014
Q4 | $104M | Buy |
3,509,287
+3,090,508
| +738% | +$88.6M | 1.24% | 7 |
|
|
2014
Q3 | $11.7M | Sell |
418,779
-2,987,507
| -88% | -$83.8M | 0.41% | 39 |
|
|
2014
Q2 | $95.9M | Buy |
3,406,286
+598,258
| +21% | +$17.1M | 1.1% | 9 |
|
|
2014
Q1 | $85.6M | Sell |
2,808,028
-469,198
| -14% | -$14M | 1.35% | 6 |
|
|
2013
Q4 | $95.2M | Buy |
3,277,226
+52,136
| +2% | +$1.52M | 1.44% | 6 |
|
|
2013
Q3 | $87.9M | Buy |
3,225,090
+39,245
| +1% | +$1.07M | 1.41% | 5 |
|
|
2013
Q2 | $84.7M | Buy |
+3,185,845
| New | +$88M | 1.57% | 2 |
|
Other funds holding PFE
VCM
VPM
KBC Group's PFE Position: Q1 2026 in Review
KBC Group reduced its Pfizer (PFE) stake by 7.9% in Q1 2026, selling an estimated $19.2M and leaving 8,471,914 shares worth $238M. The position accounts for 0.6% of the portfolio, ranked #22.
KBC Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $443M in Q4 2020. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- KBC Group held 8,471,914 shares of Pfizer worth $238M as of Q1 2026.
- KBC Group sold 721,799 Pfizer shares in Q1 2026, an estimated $19.2M.
- Pfizer made up 0.6% of KBC Group's portfolio in Q1 2026, its #22 holding.
- KBC Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Pfizer position peaked at $443M in Q4 2020.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.